Welcome to the Homepage of

PACT – Platform for Advanced Cellular Therapies

 

APPLY NOW

PACT Summer School 2022

New aspects in cell-based therapies –

From basic science to treatment of patients”

04 – 08 July 2022 in Vienna

 

 

PACT is happy to organize a Summer School from 04 – 08 July 2022 in Vienna.

 

This year’s summer school will focus on primary cells as source for (tissue) regeneration, therapeutic applications and test systems in human and veterinary medicine:

 

  • * improved methods for isolation, propagation and maturation of primary cells for human and animal regenerative application (cartilage, amnion, umbilical cord).
  • * the application of autologous and allogenic stem cells in human immunotherapies
  • * standardization of human cells as in vitro test systems and extracellular vesicles for clinical applications

 

 

  • The program will include class lectures and hands on courses in the lab targeting different raw materials. Furthermore, we will highlight the importance of entrepreneurial thinking, which is needed to transfer an academic result to a medical application for the benefit of patients. There will also be plenty of time for fruitful discussions with the lecturers and participants and several social events for networking.

 

Updated time schedule 

 

School credits: 2 ECTS

Please note: If you intend to receive an official report for this course, you have to co-registrate at the BOKU until 30 April 2022.

 

Fee: 250 €

The fee includes tuition and social events during the course. Accommodation and meals must be organized individually.

 

Course prerequisites:

Qualified master students as well as MScs, PhD/doctoral students and human or veterinarian medical doctors are invited to apply. We accept the application of postdocs.

 

Application:

Please complete the Application Form and send it to office@pact.ac.at.

 

Extended application deadline: 31 May 2022

Applications will undergo a selection procedure and applicants will be notified on or before the 8 June 2022 about their resulting admission to the Summer School.

 

The fee has to be transferred until 17 June 2022. Your registration will be confirmed as soon as we receive the payment.

 

Organizers: Renate Kunert, Michael B. Fischer, Christine Prenner

 

Course language: English

 

Venue:

University of Natural Resources and Life Sciences, Vienna (BOKU)

Muthgasse 11, 1190 Vienna, Austria

 

 

 

If you have any further questions please do not hesitate to contact us at office@pact.ac.at.

 

Recap EACTS – PACT Joint Symposium

„Regenerative Medicine: Taking the Science to the Patient“

30th November and 1st December 2017

Vienna, Austria

 

By the time you read this, we trust that you have returned safe and well to your work place with a motivation and determination to continue your work at least a little, in some aspect, inspired by our joint symposium.

 

The aim of scientific work in the field of regenerative medicine is to develop devices or novel cell based therapies and derived products that will serve to treat or cure disease-ridden patients. Indeed, to augment and exchange knowledge between groundbreaking fundamental research, the “clinic” and the health agencies that finally approve novel medical devices and novel drug therapies to society. With this in mind, EACTS and PACT joined forces to organize a meeting that brought together basic scientist, clinicians, regulatory affairs and service providers to discuss outlook and progress in regenerative medicine.

 

Especially in the cardiothoracic field which was the focus of this year’s symposium the “cell centric vision” is under heavy discussion after potential cell based therapies in myocardial infarction have not lived up to the expectations hypothesized by preclinical research. However, novel scientific developments like secretory products derived from cells with regenerative and/or cytoprotective capabilities can now be seen on the horizon of scientific endeavour.

 

At the Symposium, the excellent quality of the chairs, their session keynotes and speakers with your enthusiasm as participants contributed greatly to make this symposium not only successful but an exhilarating experience. At this point, we would like to thank our Sponsors again very much indeed, since without their support and loyalty such a Symposium would simply not occur. It was also very gratifying to note that so much of the “audience” was students to whom the future of our knowledge belongs and who can continue to develop their skills for patient benefit.

 

Undoubtedly, cell based therapies will come to the benefit of patients or indeed, cell derived “soups” will develop into “cocktails” or regimes for treatments that will contribute to relieve human and animal disease or suffering.

 

Finally, we would like to draw your attention to the Book of Abstracts that is available now and the Video Recordings of highlights of this Symposium that will be available by end of January 2018.

 

“What appears as the impossible is more likely to happen the more often it is attempted” let us continue to work together in “Taking the Science to the Patient”.

 

Michael Comer, Hendrik Jan Ankersmit, Beatrix Mayer-Reinprecht

 

We cordially welcome our new Institute Member

Center for Translational Medicine (CTM)

International Clinical Research Center 

St. Anne’s University Hospital Brno

 

St. Anne’s University Hospital Brno
International Clinical Research Center
Pekařská 53
656 91 Brno
Czech Republic

www.fnusa-icrc.org

 

The Center for Translational Medicine (CTM) is a highly interdisciplinary research platform in the International Clinical Research Center (FNUSA-ICRC), a European Union-funded project of the St. Anne’s University Hospital Brno (Czech Republic). The funds so far collected from EU were mostly used to build its own state-of-the-art translational medical research premises. The research center, currently hosts young promising researchers and students from all over the world (9 nationalities represented) and aims at unveiling the molecular mechanisms involved in the onset and progression of the diseases of aging. For this purpose, CTM adopts original and interdisciplinary approaches based on the use of smart materials, microfluidics systems, bioreactors, mechanically-assisted devices and multi-faceted molecular and cellular biology skills to investigate the molecular basis of complex diseases.  more

 
 

Stem Cells‬ for Age-related Macular Degeneration

Nature News: Japanese woman is first recipient of next-generation stem cells. Surgeons implanted retinal tissue created after reverting the patient’s own cells to ‚pluripotent‘ state.